Literature DB >> 32200875

Recent Advances in Understanding Pemphigus and Bullous Pemphigoid.

Christoph M Hammers1, John R Stanley2.   

Abstract

For many years, The Journal of Investigative Dermatology (JID) has been a leader in our understanding of many aspects of the major autoimmune blistering skin diseases, pemphigus and bullous pemphigoid. The purpose of this review is to highlight and summarize those advances by discussing the respective articles, published in the JID from 2015 to 2019. Seminal articles from elsewhere in the literature that set the stage for those advances, or that are "classics" in the area, are also included to provide context and a more complete picture.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32200875     DOI: 10.1016/j.jid.2019.11.005

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

Review 1.  [Paraneoplastic autoimmune dermatoses].

Authors:  D Didona; M Hertl
Journal:  Hautarzt       Date:  2021-03-01       Impact factor: 0.751

2.  Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases.

Authors:  Yanxia Bi; Jian Su; Shengru Zhou; Yingjie Zhao; Yan Zhang; Huihui Zhang; Mingdong Liu; Aiwu Zhou; Jianrong Xu; Meng Pan; Yiming Zhao; Fubin Li
Journal:  Elife       Date:  2022-08-03       Impact factor: 8.713

Review 3.  Immunotherapy for Pemphigus: Present and Future.

Authors:  Huijie Yuan; Meng Pan; Hongxiang Chen; Xuming Mao
Journal:  Front Med (Lausanne)       Date:  2022-06-15

Review 4.  Pemphigus and Pemphigoid: From Disease Mechanisms to Druggable Pathways.

Authors:  Christoph T Ellebrecht; Damian Maseda; Aimee S Payne
Journal:  J Invest Dermatol       Date:  2021-10-29       Impact factor: 7.590

Review 5.  Milestones in Personalized Medicine in Pemphigus and Pemphigoid.

Authors:  Katja Bieber; Khalaf Kridin; Shirin Emtenani; Katharina Boch; Enno Schmidt; Ralf J Ludwig
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

Review 6.  Translational autoimmunity in pemphigus and the role of novel Bruton tyrosine kinase inhibitors.

Authors:  Piyu Parth Naik
Journal:  J Transl Autoimmun       Date:  2022-04-16

7.  Use of gliptins reduces levels of SDF-1/CXCL12 in bullous pemphigoid and type 2 diabetes, but does not increase autoantibodies against BP180 in diabetic patients.

Authors:  Antti Nätynki; Päivi Leisti; Jussi Tuusa; Outi Varpuluoma; Laura Huilaja; Kentaro Izumi; Sanna-Kaisa Herukka; Olavi Ukkola; Juhani Junttila; Nina Kokkonen; Kaisa Tasanen
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

Review 8.  Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein.

Authors:  Ambreen Rehman; Yunying Huang; Hong Wan
Journal:  Life (Basel)       Date:  2021-06-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.